Home › Sleep Disorders › Florida › St. Petersburg
Sleep Disorders clinical trials in St. Petersburg, FL
3 studies for Sleep Disorders are looking for participants at sites in and around St. Petersburg (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Do Not Use a Breathing Machine (PAP) (VESPER-OSA 2)
RecruitingPhase 3
- DM Clinical Research-Bradenton, Bradenton · 20 mi away
A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1)
RecruitingPhase 3
- DM Clinical Research, Bradenton · 20 mi away
A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence
RecruitingPhase 2/3
- St. Petersburg, Florida, St. Petersburg
About Sleep Disorders
Getting a good sleep is vital to your health, but many Americans don't get enough. Learn about sleep disorders, treatments, and good sleep habits.
More about Sleep Disorders on MedlinePlus
Sleep Disorders trials in other cities
- San Antonio, TX6 studies
- Lansing, MI5 studies
- Cincinnati, OH5 studies
- Sugar Land, TX5 studies
- Charlotte, NC5 studies
- Orlando, FL5 studies
- Brandon, FL5 studies
- Dallas, TX4 studies
- Macon, GA4 studies
- Austin, TX4 studies
- Miami, FL4 studies
- Columbia, SC4 studies
Other studies in St. Petersburg
- Non-Small Cell Lung Cancer21 studies
- Breast Cancer10 studies
- Obesity9 studies
- Overweight9 studies
- Colorectal Cancer8 studies
- Heart Failure7 studies
- COPD6 studies
- Burkitt Lymphoma6 studies
- Cancer (all types)6 studies
- Ovarian Cancer6 studies
- Endometrial Cancer6 studies
- Lung Cancer6 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.